Current status of patients with buerger disease in Japan
1Department of Vascular Surgery, Aichi Medical University, Nagakute, Aichi, Japan.
Insights
This study analyzed Japanese patients with Buerger disease (thromboangiitis obliterans). The findings indicate a favorable clinical course for thromboangiitis obliterans patients in Japan, with manageable limb morbidity and mortality rates.
Area of Science:
- Vascular Medicine
- Epidemiology
Background:
- Buerger disease, also known as thromboangiitis obliterans (TAO), is a rare inflammatory condition affecting blood vessels, primarily in the limbs.
- Understanding the prevalence and clinical characteristics of TAO is crucial for effective patient management and public health planning in Japan.
Purpose of the Study:
- To analyze the prevalence and clinical characteristics of Japanese patients diagnosed with thromboangiitis obliterans (TAO).
- To estimate the current number of TAO patients in Japan and assess their clinical outcomes.
Main Methods:
- Utilized the Ministry of Health, Labour and Welfare (MHLW) database from 2009.
- Included 129 newly diagnosed patients and 3639 patients undergoing follow-up, adhering to established clinical criteria for TAO.
Main Results:
- Estimated the total number of patients with thromboangiitis obliterans (TAO) in Japan to be approximately 4000.
- Observed a relatively favorable clinical course for TAO patients.
- Reported that rates of limb morbidity and mortality were not entirely discouraging.
Conclusions:
- The study provides valuable epidemiological data on thromboangiitis obliterans (TAO) in Japan.
- The findings suggest that TAO management in Japan may lead to relatively positive patient outcomes.
- Further research can build upon these findings to improve care for patients with Buerger disease.
Abstract:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF JAPANESE PATIENTS WITH BUERGER DISEASE (THROMBOANGIITIS OBLITERANS: TAO) were analyzed based on the Ministry of Health, Labour and Welfare (MHLW) database in 2009. A total of 129 new patients and 3639 patients in follow-up were selected according to the clinical criteria of TAO. The current number of patients with TAO in Japan is estimated at about 4000. The clinical course is relatively favorable, and the rates of limb morbidity and mortality were not completely discouraging.
Related Concept Videos
Pedigree Analysis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

